Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





30-Second COVID-19 Breathalyzer Test Could Be a Game-Changer

By LabMedica International staff writers
Posted on 13 Oct 2020
India and Israel are jointly developing a new rapid COVID-19 testing kit that will simply require an individual to blow into a tube and deliver results in less than a minute, making the test a real game-changer.

Israeli Ambassador to India Ron Malka told the Indian news agency PTI that the test should be ready in “a matter of days.” In the operation dubbed “Open Skies,” inspired by the belief that the testing kit will enable the world to begin opening the skies, Israel has sent a high level research delegation to India for conducting a series of "final stages of testing" to develop the rapid COVID-19 testing kit. More...
The team of researchers has conducted trials using a large number of samples in India for four different kinds of technologies having the capabilities to rapidly detect SARS-CoV-2, namely sound waves, breathalyzers based on terahertz waves, isothermic identification and checking polyamino acids. According to Malka, each test has passed different stages of evaluation. The test would be extremely cheap to perform, as it would deliver results locally and eliminate logistics as well as the cost involved for sending samples to the laboratory. Malka said that India was likely to become the manufacturing headquarters for the new rapid test kit and experts from both the countries also planned to jointly develop COVID-19 vaccines.

"It will be good news for the entire world. Until we manage to immunize the entire population, this joint operation, which we had named 'open skies', would literally open the skies in terms of international travel and other economic activities as this can be used at airports and other places by requiring a person just to blow into a tube and the result would be available in 30-40-50 seconds," Malka told PTI.



Gold Member
Multiplex Genetic Analyzer
MassARRAY Dx Analyzer (Europe only)
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Clinical Chemistry System
P780
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Research has linked platelet aggregation in midlife blood samples to early brain markers of Alzheimer’s (Photo courtesy of Shutterstock)

Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk

Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more

Microbiology

view channel
Image: Development of targeted therapeutics and diagnostics for extrapulmonary tuberculosis at University Hospital Cologne (Photo courtesy of Michael Wodak/Uniklinik Köln)

Blood-Based Molecular Signatures to Enable Rapid EPTB Diagnosis

Extrapulmonary tuberculosis (EPTB) remains difficult to diagnose and treat because it spreads beyond the lungs and lacks easily accessible biomarkers. Despite TB infecting 10 million people yearly, the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.